Africa

Tanzania confirms first-ever cases of Marburg Virus Disease

Five out of eight cases, including a health worker, have died and the remaining three are receiving treatment as WHO supports the government's efforts to control the outbreak.

By Amope Oniroyin

March 21, 2023

Tanzania has confirmed its first-ever cases of Marburg Virus Disease, after laboratory tests were carried out following reports of cases and deaths in the country’s north-west Kagera region. According to the country’s National Public Health Laboratory, eight people developed symptoms including fever, vomiting, bleeding and renal failure. Five of the eight cases, including a health worker, have died, and the remaining three are receiving treatment. A total of 161 contacts have been identified and are being monitored.

In response to the outbreak, the World Health Organization (WHO) is supporting Tanzania’s Ministry of Health to deploy an emergency team to Kagera to carry out further epidemiological investigations. “The efforts by Tanzania’s health authorities to establish the cause of the disease is a clear indication of the determination to effectively respond to the outbreak. We are working with the government to rapidly scale up control measures to halt the spread of the virus and end the outbreak as soon as possible,” said Dr Matshidiso Moeti, WHO Regional Director for Africa.

Marburg virus disease is highly virulent and causes haemorrhagic fever, with a fatality ratio of up to 88%. It is in the same family as the virus that causes Ebola virus disease. The virus is transmitted to people from fruit bats and spreads among humans through direct contact with the bodily fluids of infected people, surfaces and materials.

While Tanzania has never previously recorded a Marburg case, it has had to respond to other health emergencies including COVID-19, cholera and dengue within the past three years. “The lessons learnt, and progress made during other recent outbreaks should stand the country in good stead as it confronts this latest challenge,” said Dr Moeti. “We will continue to work closely with the national health authorities to save lives.”

According to WHO, there are no vaccines or antiviral treatments approved to treat the virus. However, supportive care – rehydration with oral or intravenous fluids – and treatment of specific symptoms, improves survival.